Press

Unlearn.AI Closes $12M Series A to Advance the Use of Digital Twins in Clinical Trials

Unlearn.AI

SAN FRANCISCO, Calif. – April 20, 2020 – Unlearn.AI, developer of the first machine-learning platform that creates Digital Twins used to populate Intelligent Control Arms in clinical studies, today announced that it has closed a $12 million Series A financing. The financing round was led by 8VC with participation from all the company’s existing investors including DCVC, DCVC Bio and Mubadala Capital Ventures. Through its investment, 8VC Principal Francisco Gimenez, Ph.D., has joined the Unlearn Board of Directors.